Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Study C38072/3084
Show Display Options
Rank Status Study
1 Completed Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab;   Drug: Matching Placebo

Indicates status has not been verified in more than two years